A cytochrome P‐450 gene family mapped to human chromosome 19 IR Phillips, EA Shephard, S Povey, MB Davis, G Kelsey, M Monteiro, ... Annals of human genetics 49 (4), 267-274, 1985 | 89 | 1985 |
Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity EJ Weber, KA Lidberg, L Wang, TK Bammler, JW MacDonald, MJ Li, ... JCI insight 3 (24), 2018 | 72 | 2018 |
Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal … SM Vieira, MB Monteiro, T Marques, AM Luna, MA Fortes, M Nery, ... BMC Medical Genetics 12, 1-6, 2011 | 41 | 2011 |
Body weight, metabolism and clock genes MM Zanquetta, ML Corrêa-Giannella, MB Monteiro, SMF Villares Diabetology & Metabolic Syndrome 2, 1-10, 2010 | 39 | 2010 |
Atlas de bioenergia do Brasil ST Coelho, MB Monteiro, MR Karniol, A Ghilardi São Paulo, 2012 | 36 | 2012 |
Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes MB Monteiro, K Thieme, DP Santos-Bezerra, MS Queiroz, V Woronik, ... Metabolism 65 (6), 816-824, 2016 | 34 | 2016 |
Gain-of-function variants in NLRP1 protect against the development of diabetic kidney disease: NLRP1 inflammasome role in metabolic stress sensing? JLS Soares, FP Fernandes, TA Patente, MB Monteiro, MC Parisi, ... Clinical Immunology 187, 46-49, 2018 | 33 | 2018 |
Thioredoxin interacting protein expression in the urinary sediment associates with renal function decline in type 1 diabetes MB Monteiro, DP Santos-Bezerra, K Thieme, SN Admoni, RV Perez, ... Free radical research 50 (1), 101-110, 2016 | 27 | 2016 |
Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 … MB Monteiro, TA Patente, K Mohammedi, MS Queiroz, MJ Azevedo, ... Free radical research 47 (10), 804-810, 2013 | 26 | 2013 |
Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes K Mohammedi, TA Patente, N Bellili-Muñoz, F Driss, MB Monteiro, ... Diabetologia 56, 2733-2742, 2013 | 21 | 2013 |
Mapping studies with peptidase-D (PEPD) S Ball, KE Buckton, G Corney, G Fey, M Monteiro, JE Noades, B Pym, ... Cytogenetics and Cell Genetics 37 (1-4), 411-412, 1984 | 20 | 1984 |
Optimization of total RNA isolation from human urinary sediment MB Monteiro, DP Santos-Bezerra, K Thieme, M Passarelli, UF Machado, ... Clinica Chimica Acta 462, 158-161, 2016 | 19 | 2016 |
Glutathione peroxidase 4 functional variant rs713041 modulates the risk for cardiovascular autonomic neuropathy in individuals with type 1 diabetes SN Admoni, DP Santos-Bezerra, RV Perez, TA Patente, MB Monteiro, ... Diabetes and Vascular Disease Research 16 (3), 297-299, 2019 | 18 | 2019 |
A Sustentabilidade da expansão da cultura canavieira ST Coelho, PM Guardabassi, BA Lora, M Monteiro, R Gorren Centro de Referencia em Biomassa–CENBIO–USP. Cadernos Técnicos da Associação …, 2007 | 18 | 2007 |
N-acetyl cysteine attenuated the deleterious effects of advanced glycation end-products on the kidney of non-diabetic rats K Thieme, KS Da Silva, NT Fabre, S Catanozi, MB Monteiro, ... Cellular physiology and biochemistry 40 (3-4), 608-620, 2016 | 17 | 2016 |
A Systems Toxicology Approach for the Prediction of Kidney Toxicity and Its Mechanisms In Vitro S Ramm, P Todorov, V Chandrasekaran, A Dohlman, MB Monteiro, ... Toxicological Sciences 169 (1), 54-69, 2019 | 16 | 2019 |
Localization of PEPD to the long arm of chromosome 19 MB Davis, D Schonk, M Monteiro, F Oerlemans, S Povey, B Wieringa Annals of human genetics 51 (3), 195-199, 1987 | 16 | 1987 |
Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 … DP Santos-Bezerra, A Machado-Lima, MB Monteiro, SN Admoni, ... Diabetes and Vascular Disease Research 15 (1), 81-89, 2018 | 15 | 2018 |
The effects of combined training on bone metabolic markers in postmenopausal women A Pereira, AM Costa, A Palmeira-de-Oliveira, J Soares, M Monteiro, ... Science & Sports 31 (3), 152-157, 2016 | 13 | 2016 |
Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease KA Lidberg, AJ Annalora, M Jozic, DJ Elson, L Wang, TK Bammler, ... Scientific reports 11 (1), 4722, 2021 | 11 | 2021 |